O.C.G.A.
O.C.G.A. § 33-24-59.19 (2019)
Coverage for treatment of burns with skin substitutes utilizing cryopreserved cadaver derived skin tissue
✓ O.C.G.A. — 2019 edition (Public.Resource.Org Release 73)
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases:
SyfertCases citing this section
GA-LEGlegis.ga.gov (official)
JustiaJustia
CornellLII Search
CasesGoogle Scholar
No health benefit policy issued, delivered, or renewed in this state that, as a provision of hospital, medical, or surgical services, directly or indirectly covers the treatment and management of burns shall limit or exclude coverage for such treatment on the basis that the use of cryopreserved cadaver derived skin tissue is an experimental or investigational medical treatment.
History
Code 1981, § 33-24-59.19, enacted by Ga. L. 2015, p. 1317, § 1/HB 409.
Annotations
Code Commission notes. - Pursuant to Code Section 28-9-5, in 2015, Code Section 33-24-59.18, as enacted by Ga. L.
2015, p. 1317, § 1/HB 409, was redesignated as Code Section 33-24-59.19.
Law reviews. - For article, ‘‘Reforming Regenerative Medicine Regulation,’’ see 34 Ga. St. U. L. Rev. 631 (2018).